Derivatives of 2-(8,9-dioxo-2,6-diazabicyclo(5.2.0)non -1(7)-en-2-yl)alkyl phosphonic acid and their use as N-methyl-D-aspartate (NMDA) recetor antagonists

Details for Australian Patent Application No. 2004230895 (hide)

International Classifications

Event Publications

10 November 2005 PCT application entered the National Phase

PCT publication WO2004/092189 Priority application(s): WO2004/092189

9 September 2010 Application Accepted

Published as AU-B-2004230895

2 December 2010 Application for Amendment

The nature of the amendment is: Amend the invention title to read Derivatives of 2-(8,9-dioxo-2,6-diazabicyclo(5.2.0)non-1(7)-en-2-yl)alkyl phosphonic acid and their use as N-methyl-D-aspartate (NMDA) receptor antagonists. Address for service in Australia - Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000

24 March 2011 Amendment Made

31 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.